4.5 Article

Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials

Related references

Note: Only part of the references are listed.
Article Genetics & Heredity

Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer

Esther H. Lips et al.

Summary: A genomic analysis of ductal carcinoma in situ (DCIS) samples reveals that a significant portion of invasive breast cancer recurrences are unrelated to the initial DCIS and have distinct clonal origins. This finding is crucial for accurately assessing the risk of DCIS, developing effective treatment strategies, and identifying predictive biomarkers.

NATURE GENETICS (2022)

Article Medicine, General & Internal

Association of Adherence to Endocrine Therapy Among Patients With Breast Cancer and Potential Drug-Drug Interactions

Elie Rassy et al.

Summary: Suboptimal adherence to endocrine therapy (ET) significantly affects survival outcomes among patients with hormone-receptor-positive breast cancer. This study examines the association between potential drug-drug interactions (PDDI) with tamoxifen or aromatase inhibitor and adherence to ET in breast cancer patients.

JAMA NETWORK OPEN (2022)

Article Oncology

Second invasive breast cancers in patients treated with breast-conserving therapy

Jin Wang et al.

Summary: After breast-conserving therapy, patients may experience ipsilateral breast tumor recurrence, new primary tumor, or contralateral breast cancer. Patients with true recurrence have poorer survival outcomes compared to those with new primary tumors, while the survival outcomes of contralateral breast cancer are better.
Article Multidisciplinary Sciences

Breast tumours maintain a reservoir of subclonal diversity during expansion

Darlan C. Minussi et al.

Summary: Breast tumors and cell lines consist of numerous subclones organized into a few major superclones. Following clonal TP53 mutations, loss-of-heterozygosity events, and genome doubling, primary tumors undergo a period of transient genomic instability, with ongoing copy number evolution during expansion. Subcloned daughter cells demonstrate genomic rediversification, showing that triple-negative breast cancers continually evolve chromosome aberrations and maintain subclonal diversity during primary tumor growth.

NATURE (2021)

Article Oncology

Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk

Barbara Pistilli et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Article Oncology

Breast cancer statistics, 2019

Carol E. DeSantis et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Article Oncology

Over-irradiation

Philip M. P. Poortmans et al.

BREAST (2017)

Article Oncology

High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer

Martin P. Nilsson et al.

BREAST CANCER RESEARCH AND TREATMENT (2014)

Article Oncology

Maastricht Delphi Consensus on Event Definitions for Classification of Recurrence in Breast Cancer Research

Martine Moossdorff et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)

Review Oncology

Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype

Aoife J. Lowery et al.

BREAST CANCER RESEARCH AND TREATMENT (2012)

Article Oncology

BASAL SUBTYPE OF INVASIVE BREAST CANCER IS ASSOCIATED WITH A HIGHER RISK OF TRUE RECURRENCE AFTER CONVENTIONAL BREAST-CONSERVING THERAPY

Jona A. Hattangadi-Gluth et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)

Article Mathematical & Computational Biology

A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data

Irina Ostrovnaya et al.

STATISTICS IN MEDICINE (2010)

Article Biology

Statistical tests for clonality

Colin B. Begg et al.

BIOMETRICS (2007)